Stockscreener 앱 받기
5.47
0.18%
0.010
전일 마감가:
$5.46
열려 있는:
$5.48
하루 거래량:
269.26K
Relative Volume:
0.19
시가총액:
$198.66M
수익:
$317.00K
순이익/손실:
$-53.47M
주가수익비율:
-2.8942
EPS:
-1.89
순현금흐름:
$-49.31M
1주 성능:
-4.87%
1개월 성능:
+53.22%
6개월 성능:
+264.67%
1년 성능:
+359.66%
1일 변동 폭
$5.17
$5.6179
1주일 범위
$5.165
$6.35
52주 변동 폭
$1.10
$6.35
Immuneering Corp Stock (IMRX) Company Profile
명칭
Immuneering Corp
전화
617-500-8080
주소
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE
IMRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMRX
Immuneering Corp
|
5.47 | 232.86M | 317.00K | -53.47M | -49.31M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.39 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.14 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.86 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
750.59 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.00 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Immuneering Corp Stock (IMRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-03-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-03-15 | 재확인 | Needham | Buy |
| 2024-03-15 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-12-01 | 개시 | Needham | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-04-19 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-04-19 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-03-30 | 개시 | Mizuho | Neutral |
| 2023-02-03 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-07-08 | 개시 | Chardan Capital Markets | Buy |
| 2022-04-01 | 개시 | Oppenheimer | Outperform |
| 2022-01-07 | 개시 | Piper Sandler | Overweight |
모두보기
Immuneering Corp 주식(IMRX)의 최신 뉴스
Using Python tools to backtest Immuneering Corporation strategiesJuly 2025 Pullbacks & Weekly Top Gainers Alerts - Newser
Tick level data insight on Immuneering Corporation volatilityJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - Newser
Custom watchlist performance reports with Immuneering CorporationTrade Risk Summary & Free Growth Oriented Trading Recommendations - Newser
Aug Reactions: Will Immuneering Corporation stock recover after earningsQuarterly Performance Summary & Technical Confirmation Trade Alerts - khodrobank.com
Can Immuneering Corporation ride the EV waveJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - khodrobank.com
Immuneering Corporation (IMRX) files for up to 9.18M share offering by selling stockholders - StreetInsider
Buyback Watch: Can Immuneering Corporation deliver consistent dividends2025 Growth vs Value & Verified Swing Trading Watchlist - khodrobank.com
Can a trend reversal in Immuneering Corporation lead to recoveryJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser
Order flow analysis tools used on Immuneering CorporationWeekly Gains Summary & High Conviction Trade Alerts - Newser
How hedge fund analytics apply to Immuneering Corporation stockMarket Movement Recap & Daily Profit Focused Stock Screening - Newser
Building trade automation scripts for Immuneering CorporationBreakout Watch & Safe Swing Trade Setups - Newser
What momentum shifts mean for Immuneering CorporationRisk Management & Technical Pattern Alert System - Newser
Is Immuneering Corporation a cyclical or defensive stockShort Setup & Growth Oriented Trading Recommendations - khodrobank.com
Understanding Immuneering Corporation’s price movementJuly 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Does Immuneering Corporation show high probability of reboundShare Buyback & Daily Oversold Bounce Ideas - Newser
Can Immuneering Corporation recover in the next quarterJuly 2025 Institutional & Fast Momentum Stock Entry Tips - Newser
What machine learning models say about Immuneering CorporationOil Prices & Real-Time Stock Entry Alerts - Newser
Is Immuneering Corporation stock entering bullish territoryQuarterly Performance Summary & Fast Momentum Entry Tips - Newser
Can Immuneering Corporation expand into new markets2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - 한국정경신문
Leading vs lagging indicators on Immuneering Corporation performance2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Published on: 2025-08-29 00:05:44 - Newser
Live market analysis of Immuneering CorporationTake Profit & Growth Focused Stock Pick Reports - Newser
Published on: 2025-08-28 12:45:47 - Newser
Immuneering Corporation stock prediction for this weekJuly 2025 Retail & AI Forecasted Entry and Exit Points - Newser
How Immuneering’s financial strategy fuels scientific breakthroughs - BioXconomy
Immuneering Corp (IMRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Immuneering Corp 주식 (IMRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| HAUSMAN DIANA | Director |
Jul 02 '25 |
Buy |
3.60 |
2,500 |
8,989 |
2,500 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER |
Jul 02 '25 |
Buy |
3.57 |
700 |
2,499 |
10,729 |
| Zeskind Benjamin J. | PRESIDENT AND CEO |
Jul 02 '25 |
Buy |
3.53 |
7,015 |
24,792 |
2,312,852 |
| Zeskind Benjamin J. | PRESIDENT AND CEO |
Jul 01 '25 |
Buy |
3.38 |
2,985 |
10,087 |
2,305,837 |
| Schall Thomas J. | Director |
Jun 27 '25 |
Buy |
3.66 |
9,500 |
34,788 |
52,885 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER |
Jun 20 '25 |
Buy |
2.70 |
7,415 |
20,020 |
353,311 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER |
Jun 23 '25 |
Buy |
2.43 |
6,007 |
14,596 |
359,318 |
| Brakewood Harold Eugene | Chief Business Officer |
Jun 20 '25 |
Buy |
2.53 |
1,900 |
4,804 |
5,800 |
| Feinberg Peter | Director |
Jun 18 '25 |
Buy |
2.53 |
25,000 |
63,188 |
136,766 |
| Zeskind Benjamin J. | PRESIDENT AND CEO |
Jun 18 '25 |
Buy |
2.39 |
21,000 |
50,144 |
2,302,852 |
0.76%
자본화:
|
볼륨(24시간):